Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02181192
What this trial is testing

Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma

Who this might be right for
Prostate CancerRecurrence
University of Erlangen-Nürnberg Medical School 180
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Testing effectiveness (Phase 2)UnknownNCT02844699
What this trial is testing

Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer

Who this might be right for
Prostate Cancer
Panacela Labs LLC 24
Testing effectiveness (Phase 2)Temporarily pausedNCT05199311
What this trial is testing

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 66
Testing effectiveness (Phase 2)Study completedNCT00210314
What this trial is testing

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, B Cell
International Extranodal Lymphoma Study Group (IELSG) 79
Not applicableEnded earlyNCT02131207
What this trial is testing

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 139
Large-scale testing (Phase 3)UnknownNCT00378365
What this trial is testing

Acute Promyelocytic Leukemia 2006 (APL)

Who this might be right for
Leukemia, Promyelocytic, Acute
Assistance Publique - Hôpitaux de Paris 800
Testing effectiveness (Phase 2)Ended earlyNCT01864798
What this trial is testing

Evaluate Denosumab in Young Patients With Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Jules Bordet Institute 27
Large-scale testing (Phase 3)Study completedNCT00482833
What this trial is testing

Phase III Trial in Acute Promyelocytic Leukemia Patients

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 276
Testing effectiveness (Phase 2)Study completedNCT00602771
What this trial is testing

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Testing effectiveness (Phase 2)Ended earlyNCT01186406
What this trial is testing

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma MultiformeGliosarcoma
Duke University 41
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Early research (Phase 1)Not Yet RecruitingNCT07722767
What this trial is testing

A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients

Who this might be right for
AML (Acute Myeloid Leukemia)
Cullinan Therapeutics Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05389293
What this trial is testing

Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Who this might be right for
Follicular LymphomaLymphoma
Memorial Sloan Kettering Cancer Center 152
Post-approval studies (Phase 4)Study completedNCT00212433
What this trial is testing

Optimisation and Performance of Reduced Preparation CT Colography

Who this might be right for
Patients With Potential Colorectal Neoplasia
London North West Healthcare NHS Trust 120
Not applicableEnded earlyNCT02027649
What this trial is testing

Detection of K14 in Bladder Cancer With a Non Invasive Technique

Who this might be right for
Bladder Cancer
Corporacion Parc Tauli 400
Not applicableUnknownNCT03469726
What this trial is testing

Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Radboud University Medical Center 465
Not applicableNot Yet RecruitingNCT07616726
What this trial is testing

Exploration and Characterization Ofintratumoral Electrophysiological Heterogeneity in Gliomas Using Magnetoencephalography

Who this might be right for
Patients Diagnosed With a Malignant Glioma
Hospices Civils de Lyon 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06548347
What this trial is testing

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd. 606
Next Page